Cutaneous venous dysfunction studied in vivo in the LPS-treated rabbit: Implication of NO in saphenous vein hyporeactivity

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 5, 2003, Pages 516-523

  Vayssettes Courchay, Christine ^a   Chataigneau, Marta ^a   Protin, Cedric ^a   Ragonnet, Christophe ^a   Verbeuren, Tony J ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Acetylcholine; Endothelium; Inflammation; Nitric oxide synthase; Noradrenaline; Sepsis; Venoconstriction; Venodilatation

Indexed keywords

ACETYLCHOLINE; BACTERIUM LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; NORADRENALIN; PENTOBARBITAL; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTOXEMIA; HEART RATE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERIPHERAL VEIN; RABBIT; SAPHENOUS NERVE; SKIN BLOOD VESSEL; VASCULAR ENDOTHELIUM; VEIN DIAMETER; VEIN DILATATION; VEIN DISEASE; VENOCONSTRICTION;

ACETYLCHOLINE; ANIMALS; BLOOD PRESSURE; ENDOTOXEMIA; HYPOTENSION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LYSINE; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; POLYSACCHARIDES, BACTERIAL; RABBITS; SAPHENOUS VEIN; SKIN; SUMATRIPTAN; VASCULITIS; VASOCONSTRICTION; VASODILATION;

EID: 0038119928     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0712-9     Document Type: Article

References (39)

1. Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, Gajdos P (1999) Inappropriate sympathetic activation at onset of septic shock. Am J Resp Crit Care Med 160:458-465
2. Auclair MC, Carli A, Lechat P (1982) Decrease of the hypertensive responses to phenylephrine in the rat submitted to a sublethal dose of E. coli endotoxin. Restoration by indomethacin. J Pharmacol 13:341-351
3. Behr D, Rupin A, Fabiani J-N, Verbeuren T (1999) Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis 142:335-344
4. Behr-Roussel D, Rupin A, Sansilvestri-Morel P, Fabiani JN, Verbeuren TJ (2000) Histochemical evidence of inducible nitric oxide synthase in advanced but non-ruptured human atherosclerotic carotid arteries. Histochem J 32:41-51
5. Bhagat K, Vallance (1997) Inflammatory cytokines impair enothelium-dependent dilatation in human veins in vivo. Circulation 96:3042-3047
6. Bhagat K, Collier J, Vallance P (1996) Local venous responses to endotoxin in humans. Circulation 94:490-497
7. Bhagat K, Hingorani AD, Palacios M, Charles IG, Vallance P (1999) Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS. Cardiovasc Res 41:754-764
8. Coleridge-Smith PD (1999) Treatment of microcirculation disorders in venous leg ulcer. In: Messmer K (ed) Microcirculation in chronic venous insufficiency. Karger, Munich, pp 121-141
9. Dalsing MC, Zurowski AJ, Unthank JL, Lalka SG, Sawchuk AP, Cikrit DF (1994) Details of a canine venous insufficiency model. J Invest Surg 7:85-93
10. Ermert M, Ruppert C, Gunther A, Duncker HR, Seeger W, Armert L (2002) Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 82:425-441
11. Fleming I, Dambacher T, Busse R (1992) Endothelium-derived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide. J Cardiovasc Pharmacol 20 [Suppl 12]:135-138
12. Gray GA, Schott C, Julou-Schaeffer G, Fleming I, Parrat JR, Stoclet J-C (1991) The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 103:1218-1224
13. Gunnet CA, Cho Y, Heistad DD, Loihl A, Faraci F (1998) Vascular effects of LPS in mice deficient in expression of gene for inducible nitric oxide synthase. Am J Physiol 275:H416-H421
14. Hollenberg SM (1998) A yellow light for nitric oxide synthase inhibitors in sepsis: proceed with caution. Crit Care Med 26:815-816
15. Huang K-T, Kuo L, Liao JC (1998) Lipopolysaccharide activates endothelial nitric oxide synthase through protein tyrosine kinase. Biochem Biophys Res Commun 245:33-37
16. Joly GA, Schini VB, Vanhoutte PM (1992) Balloon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries. Circ Res 71:331-338
17. Jones SB, Kotsonis P, Majewski H (1994) Endotoxin enhances norepinephrine release in the rat peripheral mechanisms. Shock 2:370-375
18. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parrat JR Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259: H1038-H1043
19. Gmethyl-l-arginine, inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci 87:3629-3632
20. Lalka SG, Unthank JL, Dalsing MC, Cikrit DF, Sawchuk AP (1990) Venous hemodynamics in a chronic venous valvular insufficiency model. Arch Surg 125:1579-1583
21. MacMicking JD, Nathan C, Hom G (1995) Altered responses to infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650
22. Nakaki T, Otsuka Y, Nakayama M, Kato R (1992) Endothelium-accelerated hyporesponsiveness of norepinephrine - elicits contraction of rat aorta in the presence of bacterial lipopolysaccharide. Eur J Pharmacol 219:311-318
23. Nava E, Palmer RMJ, Moncada S (1991) Inhibition of nitric oxide synthesis in septic shock - how much is beneficial. Lancet 338: 1555-1557
24. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons FB, Peitzman AB (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214:621-626
25. Pedoto A, Tassiopoulos AK, Oler A, McGraw DJ, Hoffmann SP, Camporesi E, Hakim TS (1998) Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide. Crit Care Med 26:2021-2028
26. Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors in patients with septic shock. Lancet 338:1557-1558
27. Salvemini D, Korbut R, Anggard E, Vane J (1990) Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 87:2593-2597
28. Scott JA, McCormack G (1999) Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis. J Appl Physiol 86:1739-1744
29. Szabó C, Mitchell JA, Thiemermann C, Vane JR (1993) Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 108:786-792
30. Thiemermann C, Vane J (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharide in the rat in vivo. Eur J Pharmacol 182:591-595
31. Thorin-Trescases N, Hamilton CA, Reid JL, Bohr D, Dominiczak AF (1995) Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. Am J Physiol 268:H1122-H1132
32. Vallance P, Palmer RMJ, Moncada S (1992) The role of nitric oxide synthesis in the altered responses of jugular veins from endotoxaemic rabbits. Br J Pharmacol 106:459-463
33. Van Bemmelen SP, Hoynck van Papendrecht AA, Hodde KC, Klopper PJ (1986) A study of valve incompetence that developed in an experimental model of venous hypertension. Arch Surg 121:1048-1052
34. Vayssettes-Courchay C, Cordi AA, Lacoste J-M, Laubie M, Verbeuren TJ (1997) Recording of the saphenous vein compliance by an ultrasonic echo-tracking device in the dog: effects of S18149. Br J Pharmacol 122:1361-1366
35. Vayssettes-Courchay C, Ragonnet C, Verbeuren TJ (2000) In vivo analysis of adrenergic and serotoninergic constrictions of the rabbit saphenous vein. Eur J Pharmacol 408:277-288
36. Verbeuren TJ (2003) Microvascular adhesion mechanisms in chronic venous insufficiency: a pharmacological approach. In: Schmid-Schönbein GW, Granger ND (eds) Molecular basis of microcirculatory disorders. Springer, Berlin Heidelberg New York
37. Verbeuren TJ, Bouskela E, Cohen RA, Vanhoutte PM (2000) Regulation of adhesion molecules: a new target for the treatment of chronic venous insufficiency. Microcirculation 7:S41-S48
38. Wort SJ, Evans TW (1999) The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull 55:30-48
39. Wright CE, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57